CVIA Journal

Cardiovascular Innovations and Applications

29th great wall International conference GWICC

Joint Forums – 29th Great Wall International Congress of Cardiology (GWICC)

The 29th GW-ICC, takes place October 11th -14th, 2018, in Beijing, China. It has become a tradition for world renowned cardiology associations to send delegations to GWICC congresses. Details of the sessions to be held at this year’s congress are as follows: 

ACC@GW-ICC Joint Sessions

The American College of Cardiology (ACC) and the Great Wall International Congress of Cardiology (GWICC) have enjoyed a history of mutual collaboration over the last 11 years. The ACC is excited to have three joint sessions at the 29th GWICC on the topics of Prevention, Intervention and Imaging. ACC President, C. Michael Valentine, MD, FACC, will lead the delegation to Beijing.

Chairs and speakers

Pamela Morris, MD, FACC, co-chair of ACC’s Annual Scientific Committee

Akshay Khandelwal, MD, FACC, incoming chair, Board of Governors

Robert Hendel, MD, FACC, ACC trustee

Ed Fry, MD, FACC, ACC trustee,

Christopher Kramer, MD, FACC, ACC trustee

Y.S. Chandrashekhar, MD, FACC

Nanette Wenger, MD, MACC

Dipti Itchhaporia, MD, FACC

AHA@GW-ICC Joint Session

American Heart Association (AHA)

Session title: Hypertension 2018: Understanding Genetics, Prevention Strategies and Management

Brief Description: Over a billion people around the world have hypertension, which is said to be the most important risk factor for premature cardiovascular disease. Yet we do not know the root cause for most cases of hypertension. In this session Professor Ivor Benjamin will discuss studies that are helping us understand genetic origins of high blood pressure. We will also hear from Professor Sidney Smith about treatment strategies for patients with confirmed hypertension according to the new AHA/ACC hypertension guidelines.

Session title: Contemporary Issues in Cardiopulmonary Resuscitation

Speakers: AHA co-chair: Professor Ivor Benjamin (Milwaukee, USA)

Professor Sidney C. Smith, Jr (Chapel Hill, USA) “Public Awareness of Cardiac Arrest, CPR, and AEDs”

Professor Michael Sayre (Seattle, USA) “”Measure and Improve: Saving Lives from Out-of-Hospital Cardiac Arrest”

Brief Description: Cardiac arrest is responsible for more than 360,000 deaths per year in the United States alone, and out-of-hospital cardiac arrest (OHCA) is a leading cause of death in many countries around the world. Professor Smith will discuss the importance of public awareness of what out-of-hospital cardiac arrest is. People who suffer a cardiac arrest will likely die if not treated. However, OHCA may be reversed if cardiopulmonary resuscitation (CPR) is performed and an automated external defibrillator (AED) is used to shock the heart and restore a normal heart rhythm within a few minutes. Bystanders who witness a cardiac arrest and know how to perform CPR and use an AED can quadruple the victim’s chances of survival. Professor Sayre’s presentation will give an overview of ten programs to measure the incidence and improve the treatment, and raise long-term survival from OHCA. For example, increasing OHCA survival from 1% to 5% could save about 400 additional lives per year in Beijing alone.

CAAC-ATVB@GM-ICC Joint Session

Course Title Mechanism of Vascular Disease, Immunity and Metabolic Disorders

Brief Description: ATVB is the Council on Arteriosclerosis, Thrombosis and Vascular Biology of American Heart Association (AHA). ATVB engages scientists and clinicians working to improve the prevention, diagnosis and treatment of atherosclerotic, vascular, and thrombotic diseases in the US and worldwide. Council membership includes investigators with interests that range from discovery science to clinical research. We promote international collaboration and network in cardiovascular Research. In cooperation with Chinese American Academy of Cardiology (CAAC), we started the collaboration with GW-ICC since 2015 and jointly hosted the ATVB@GW-ICC for the past 5 years.  

Speakers:

Dr. Hong Wang is an Endowed Chair Professor, the Director of the Center for Metabolic Disease Research and Chair of department of Microbiology and Immunology from Lewis Katz School of Medicine at Temple University. President of Research of CAAC, a member of AHA ATVB Award Committee, Membership/Communication Committee & Women’s leadership Committee, a member of AHA FGTB Leadership Committee, Dr Wang is a leading scientist in atherosclerosis and vascular inflammation research.

Dr. Jonathan David Smith is an Endowed Chair professor, and the Chair of Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine from Cleveland Clinic, Ohio, USA. Dr Smith is a member of ATVB Award Committee, and an expert in cell/molecular biology, biochemistry, and genetics/genomics related to cardiovascular disease.

Dr. Nicholas James Leeper is an Associate Professor and Chief of Vascular Medicine, Director of Vascular Research from Stanford University. Chair of Early Career Committee (ATVB council), member of Membership and Communications Committee (PVD council) and Member at Large, Science Advisory and Coordinating Committee (AHA), Dr Leeper is a leading scientist in vascular biology of atherosclerosis and aneurysm disease research.

Dr. Chris Kevil is Editor-in-Chief of Journal of Redox Biology. Professor and vice Chancellor for Research and Dean for School of Graduate Studies, Director/P.I. of Center for Redox Biology and Cardiovascular Disease COBRE, Professor of Departments of Pathology, Molecular and Cellular Physiology, and Cell Biology and Anatomy at Louisiana State University Health Shreveport. Dr Kevil is a leading scientist in field of hydrogen sulfide (H2S) biomedical research and H2S regulates ischemic vascular remodelling.

Dr. Yabing Chen is a professor and Vice Chair of Department of Pathology from University of Alabama at Birmingham. She is the Chair of AHA/ATVB SCILL Committee, Member of AHA ATVB Leadership Committee (Scientific & Clinical Education Lifelong Learning ) and an expert in vascular calcification and atherosclerosis research.

Dr. Hua Linda Cai is a Professor of Anesthesiology and Medicine/Cardiologand and Director of Translational Research Program in the Department of Anesthesiology at University of California in Los Angeles. She is a member of Research Committee of CAAC. She is a leader in the research field of ROS signaling and endothelial biology.

 Dr. Xiaofeng Yang is a Professor and Director of faculty mentoring program from Lewis Katz School of Medicine at Temple University. He is a member of Research Committee of CAAC and a member of AHA ATVB SCILL committee. AHA FGTB Leadership Committee. He is a leading scientist in vascular immunity research.

Dr. XiaoPing Du is a Professor from University of Illinois at Chicago. He is a member of AHA ATVB SCILL committee. He is a leading scientist in platelet and thrombosis research.

AHA-BCVS@GW-ICC Joint Session

Theme: “Basic, Clinical, and Translational Medicine”.

Description: This session explores communication between cardiovascular basic research and clinical practice, and to explore the latest progress and development trend of basic and translational medicine in cardiovascular science at home and abroad from various angles and in all aspects. This forum is organized by three professors, Du Jie, Zhu Yi and Ma Xinliang. More than 60 domestic and foreign experts are invited to 12 special sessions ,and they will exchange ideas extensively on five major themes including “New Development of Basic and Clinical Progress in Cardiovascular Medicine”, “Research on Mechanisms of Vascular Homeostasis and Remodeling”, “Functional Genomics and Cardiovascular Diseases”, “Cardiovascular Repair Caused by Metabolic Disease”, and “Future Prospects for Cardiovascular Research. Four international famous experts in basic cardiovascular research from the American Heart Association, including Chief Editor of Circulation and Associate Editor of Circulation Research, are invited to discuss new points, hot spots and cold spots of cardiovascular research in the next 10 years.

AHA-CPR Workshop

The American Heart Association recently updated the Guidelines for CPR and Emergency Cardiovascular Care and also issued “Resuscitation Education Science: Educational Strategies to Improve Outcomes from Cardiac Arrest.” These science guidelines further emphasize the importance of High-Quality CPR in clinical practice, and stress standardized resuscitation training for health care provider to maintain the capability of implementing High-Quality CPR.

Leading emergency cardiovascular care clinical and educational specialists will review the latest science around High-Quality CPR and help translate the high-quality CPR into the clinical practice through resuscitation education.

High Quality CPR Challenge Workshop (Advanced Life Support)

The American Heart Association Guidelines for CPR and Emergency Cardiovascular Care emphasize that high quality Basic Life Support provides the foundation for Advanced Life Support skills. The recent statement, “Resuscitation Education Science: Educational Strategies to Improve Outcomes from Cardiac Arrest” also stresses the strategies around resuscitation education that can help healthcare provider to implement High-Quality CPR with advanced life support intervention.

Could your team’s CPR skills be improved while providing advanced intervention? Welcome to American Heart Association’ High Quality CPR Challenge Workshop (Advanced Life Support)! Leading emergency cardiovascular care clinical and educational specialists will go through the latest science around advanced life support and maintaining CPR quality while delivering advanced intervention. The workshop and interactive discussion will help you understand areas that you can improve in your own clinical setting, and to design a plan to translate the clinical into practice by using resuscitation education to achieve better patient outcomes.

AHA-GPM@GW-ICC Joint Session

Course Title: Genomics in Cardiovascular Disease

Brief Description: GPM is the Council on Genomic and Precision Medicine of American Heart Association (AHA). GPM is young, dynamic, and growing council. Our mission revolves around scientific efforts, education and career development in functional genomics, translational biology, molecular epidemiology, clinical genetics and the application of translational discoveries to clinical care. Our council members have expertise across these domains. Our culture is one around engagement and action, and a major priority of our council is the personal development of early career clinicians and scientists. Our members are actively engaged with other councils representing population and clinical science to meet the mission of the American Heart Association of reducing heart disease by 20% by 2020. In cooperation with Chinese American Academy of Cardiology (CAAC), this is the first collaboration with GW-ICC to have a joint scientific session at GWICC. The scientific theme of this session is “Genomics in Cardiovascular disease”.

Dr. Thomas J. Wang is an Endowed Chair Professor, the Division Chief of Cardiovascular Medicine, and Physician-in-Chief, Vanderbilt Heart and Vascular Institute from Vanderbilt University Medical Center. He is the Chair of AHA GPM Council. He is leading scientist in clinical cardiovascular disease and endocrinology research.

Dr. Xiaofeng Yang is a professor and Director of faculty mentoring program from Lewis Katz School of Medicine at Temple University. He is a member of Research Committee of CAAC and a member of AHA ATVB SCILL (Science & Clinical Education Life of Learning) committee. AHA FGTB Leadership Committee. He is a leading scientist in vascular immunity research.

Dr. Hong Wang is an Endowed Chair Professor, the Director of the Center for Metabolic Disease Research and Chair of department of Microbiology and Immunology from Lewis Katz School of Medicine at Temple University. She is the President of Research of CAAC, a member of AHA ATVB council Award Committee, Membership/Communication Committee, Women’s leadership Committee and SCILL Committee, and a member of AHA FGTB Leadership Committee, She is a leading scientist in atherosclerosis and vascular inflammation research.

CAAC@GW-ICC Joint Session

Course Title: CAAC @ GW-ICC : Sino-American Summit of clinical diagnose and treatment of PAH-RHF.

Course Learning Objectives: This forum invited the American Cardiologists from CAAC delegation, and American teaching hospitals affiliated with leading universities, and the top-notch Chinese Cardiologists to jointly introduce the new clinical progress and translational research advancement on pulmonary hypertension and right heart failure. The forum will be co-chaired by the CAAC Clinical President, Dr. Qiong (Joan) Zhao (Inova Heart and vascular Institute);BOT co-chair Dr. Ge Shuping (Drexel University College of Medicine);director of pulmonary vascular in institute of cardiovascular disease of PLA ,Xinqiao Hospital of the Third Military Medical University ,Dr. Lan Huang;director of state key laboratory of cardiovascular disease,Fuwai Hospital, Chinese Academy of Medical Science,Dr. Zhicheng Jin;Dr. Jieyan Shen(Renji Hospital, Shanghai JiaoTong University School of medicine);Dr.Zhiyan Han(Fuwai Hospital).

Course Title: Metabolic Disease, Thrombogenesis and Cardiac Repairing

Brief Description: CAAC, the Chinese American Academy of Cardiology is an international professional organization in Cardiovascular Medicine and research based on United States. Under the roof of CAAC, academic clinical and research cardiovascular professionals harmonically work together. Our mission is to establish a platform to facilitate communication, to promote collaboration, and to support career development for cardiovascular professional in the world. We encourage and advocate outstanding science from our members. We support career development of younger generation of cardiovascular scientists and physicians. We collaborate with colleagues in other organizations in the world to advance high standard cardiovascular research and medicine. We started collaboration with GW-ICC since 2014 and jointly hosted the CAAC@GW-ICC论坛 for the past 5 years. The scientific theme of this session is “Metabolic Disease, Thrombogenesis and Cardiac Repairing”.

Dr. Hong Wang is an Endowed Chair Professor, the Director of the Center for Metabolic Disease Research and Chair of department of Microbiology and Immunology from Lewis Katz School of Medicine at Temple University. She is the President of Research of CAAC, a member of AHA ATVB Award Committee, Membership/Communication Committee & Women’s leadership Committee, a member of AHA FGTB Leadership Committee, She is a leading scientist in atherosclerosis and vascular inflammation research.

Dr. Yabing Chen a professor and Vice Chair of Department of Pathology from University of Alabama at Birmingham. She is the Chair of AHA/ATVB SCILL Committee, Member of AHA ATVB Leadership Committee (Scientific & Clinical Education Lifelong Learning) and a expert in vascular calcification and atherosclerosis research.

Dr. XiaoPing Du is a Professor from University of Illinois at Chicago. He is a member of AHA ATVB SCILL committee. He is a leading scientist in platelet and thrombosis research.

Dr. Hua Linda Cai is a Professor of Anesthesiology and Medicine/Cardiology, and Director of Translational Research Program in the Department of Anesthesiology at University of California in Los Angeles. She is a member of Research Committee of CAAC. She is a leader in the research field of ROS signaling and endothelial biology.

Dr. Xiaofeng Yang is a Professor and Director of faculty mentoring program from Lewis Katz School of Medicine at Temple University. He is a member of Research Committee of CAAC and a member of AHA ATVB SCILL committee. AHA FGTB Leadership Committee. He is a leading scientist in vascular immunity research.

CGCF@GW-ICC Joint Session

“The 14th  China-German Cardiovascular Forum” 2018 sponsored by the Great Wall International Congress of Cardiology and the German Cardiac Society is the biggest annual joint conference of Cardiology between the two countries.

The forum will assemble together 20 top experts in the world, who are mainly from  Germany and China. They will discuss the hottest topics and frontier technology of cardiology in three different sessions, which includes: “New Trend of Valvular Heart Disease and Coronary Heart Disease”, “Left  Atrial Appendage(LAA) Closure Summit I”, “Left  Atrial Appendage Closure Summit II”. In the session of “New Trend of Valvular Heart Disease and Coronary Heart Disease””, experts from Germany and the United States will give you wonderful introduce and discussion about the complex PCI, TAVI and the new challenge of new technology  faced by cardiac surgeons.  The highlight of China-Germany Cardiovascular Forum 2018 is also focus on LAA closure which can prevent stroke or systematic thromboembolism effectively in patients with non-valvular atrial fibrillation. This includes two sessions: “Summit of LAA Closure I and Summit of LAA Closure  II”. Since the technology of LAA closure was introduced into clinical application in China in 2014, this technology has more been recognized and consistently practiced by Chinese colleagues. In both sessions, the most experienced international clinical master (Prof. Jiangtao Yu, Prof. Marcus Sandri) will do academic exchanges with many of China’s well-known experts on the same stage. These sessions cover extensive contents which mainly focus on the newest LAA closure clinical evidence in Europe/USA, standardized procedure of LAA closure, and the actual experiences in China. Meanwhile, there are some interesting and attractive debates about LAA closure to remove or form thrombus? and LAA closure procedure to be simplified or optimized? Some controversy and thought on LAA closure in the respect of the integrated management, patient selection, operation skills, one-stop program and periinterventional strategy will be presented and discussed. This academic forum will share the frontier technique and latest practical experience of LAA closure with you.  “The 14th China-Germany Cardiovascular Forum” will provide an excellent interactive platform of academic exchange. Many distinguished cardiologists from Germany and China will serve a sumptuously and professionally academic feast to the Chinese or even international colleagues. The academic forum will strongly promote high-level academic exchanges, cooperation’s and development in field of cardiovascular diseases between the two sides.

CNAHA@GW-ICC Joint Session

Chinese American Heart Association (CNAHA)

Part I: Joint Sessions

Session title: The 6th Prof. Tsung O. Cheng Honorary Lecture; Syncope and Congenital Long QT Syndrome; CNAHA-GWICC Joint Session for Structural Heart Disease

Brief Description: The 6th Prof. Tsung O. Cheng Honorary Lecture will be given by Prof. Jihong Guo a Chinese Master in cardiac electrophysiology. The Session of Syncope and Congenital Long QT Syndrome (LQTS) will cover the syncope assessment, updated re. genotype-phenotype correlation, gender effects on cardiac events and the ion channel–targeted treatment of LQTS.  Cardiomyopathies include a variety of myocardial disorders that manifest with various structural and functional phenotypes and are frequently genetic. Those conditions are challenging and often missed in clinical practice. In this section, we will present you with updated information about hypertrophic, infiltrative, constrictive and sarcoid cardiomyopathy.  With the information you receive in this this section, you should be more comfortable in managing patients with cardiomyopathies.

Part II: Joint EP Symposiums

Session titles: Atrial Fibrillation: Diagnosis and Management; Atrial Fibrillation and Ventricular Arrhythmias: Insight into the Mechanisms

Brief Description: This International Joint Session by faculty members from Chinese American Heart Association (CNAHA) and GW-ICC consists of “Clinical electrophysiology on AF Diagnosis and Treatment (Part I) and “Translational Science on Insight into Mechanisms of AF and Ventricular Arrhythmias (Part II). Faculty members in Part I will highlight the most updated information on the new definition of AF burden and anticoagulation strategy for short episodes of AF; practical approach on pharmacological and electrical cardioversion of AF; guideline-based approach for comprehensive AF care and approaches in dealing with complications such as post AF ablation-related atrial arrhythmia and thrombosis formation related to LAAC device.

By participating the Part II session, the audience will have the opportunity to learn from the six outstanding physician scientists about the latest research on the genetic basis of AF mechanisms; new signaling pathways of AF pathogenesis; prevention of atrial remodeling and AF progression; and local drug delivery via liposome to improve conduction block from radiofrequency ablation. Two faculty members in this later session will discuss the latest understanding on the mechanisms of idiopathic VF and ryanodine receptor 2 mutation-related malignant ventricular arrhythmias.

Part III: Joint Clinical Case Symposiums

Session titles: CNAHA@GWICC Clinical Case Discussions

Brief Description: Chinese American Heart Association (CNAHA) – Great Wall/International Cardiology Congress (GWICC) Joint Clinical Case Discussion Session 2018, a successful collaboration between two international organizations, will feature up-to-date presentations on the evaluation and management of severe aortic stenosis, constrictive pericarditis and syncope, with an emphasis on the systemic approach to medical decision-making in uncommon clinical pictures and advanced treatment. The program format includes interactive case-based discussions with an update from the most recent guidelines, medical, interventional and surgical perspectives to ensure a lively and relevant educational opportunity for all participants. New diagnostic tools, drugs, and devices will be reviewed along with their role in specific clinical situations. Cutting-edge research and advanced therapy will be reviewed.

HRS@GW-ICC Joint Session

Session titles: Stroke prevention in AF and sudden death prevention; Management of heart failure and ventricular tachycardia

Course Description: Great Wall/International Cardiology Congress (GW/ICC) – Heart Rhythm Society (HRS) Joint symposium 2018, more than a decade of collaboration between two international organizations, will highlight key advances in cardiac rhythm management to keep the practitioner current, with an emphasis on clinical practice and guidelines. The format of the sessions will be case-based presentations engaging faculty and audience participation. There will be questions and audience response to facilitate the exchange of the cutting-edge medical knowledge cross the Pacific. Most recent guidelines on ICD, CRT, SVT, AF and VT management will be reviewed by using case-based presentations. Indications and contraindications of the various treatment options in different arrhythmia conditions will be discussed by leaders in the field. The management and prevention of stroke in elderly patients with atrial fibrillation, and ventricular arrhythmias associated with recurrent ICD shocks will be reviewed with an update from the most recent guidelines. These sessions will be moderated and chaired by electrophysiology thought leaders in China and co-chaired by representatives from Heart Rhythm Society.

Course Learning Objective: Upon conclusion of this GW/ICC-HRS Joint Symposium, participants will have an understanding of:

  • Current guidelines on AF management, therapeutic options for treating AF and strategies for stroke prevention
  • ICD therapy, and new technologies and options for selection of ICDs
  • Appropriate use of CRT and His buddle pacing in patients with HF
  • Management of patients with recurrent ventricular tachycardia and ICD discharges with the latest technology and techniques in ventricular tachycardia ablation and other therapies

Intended Audience: The Symposium is intended for cardiologists, general internists, physician assistants, and cardiovascular nurse practitioners and electrophysiologists learning the practice guidelines and management strategies for rhythm disorders.

Japanese Circulation Society (JCS)@GW-ICC Joint Session

Session title: Heart Failure Topics – from molecular mechanisms to cutting-edge treatment

Brief Description: The number of heart failure patients has been rapidly increased all over the world and becoming more and more important. In this session, topics about heart failure such as molecular mechanisms and cutting-edge treatment will be presented and discussed.

Korean Society of Cardiometabolic Syndrome (KSCMS)@GW-ICC Joint Session

Session title: State-of-Art Cardiometabolic Syndrome

Brief Description: Cardiometabolic syndrome is very popular and becomes a huge burden to the public health. Adequate prevention and treatment are important to prevent cardiovascular events, development of type 2 diabetes, and dementia. Fortunately, recent national studies from Korea and USA reported that the prevalence is stable but does not decrease. The State-of-Art pathogenesis, prevention, and treatment will be discussed at the session.

Turkish Atherosclerosis Society (TAS)@GW-ICC Joint Session

Session title: Clinical Links of Pathogenetic Mechanisms in Atherosclerosis

Brief Description: Atherosclerosis, as being a lifelong continuum, is usually silent until the development of a cardiovascular event. On the other hand, occurrence of cardiovascular events is generally too late to detect atherosclerosis. The detection of atherosclerotic process and its clinical importance is therefore of great importance for prevention.

Besides classical risk factor/biomarker approach, clinical situations also have great importance on the development process of atherosclerosis and this link is generally underestimated. Inflammatory processes, emotional factors, metabolic load and genetic factors all act together. Therefore, the aim of this session is to evaluate some of these situations and their impact on atherosclerosis process.

Transcatheter Cardiovascular Therapeutics (TCT)@GW-ICC Joint Session

Session title: 30th TCT Anniversary Perspectives of Interventional Cardiology

Brief Description: For the last 30 years, Transcatheter Cardiovascular Therapeutics (TCT) has been educating the world in the appropriate patient selection and optimal techniques for percutaneous treatment of patients with coronary artery, endovascular and structural heart disease. This special session of TCT at the Great Wall Meeting will review the latest breakthroughs in the transcatheter treatments of patients with heart disease that were recently demonstrated at the TCT Annual Scientific Sessions in San Diego, CA, USA in September 2018, including practice-changing late-breaking trials and new therapies.

WHF@GW-ICC Joint Session

Session titles: Improving Global Cardiovascular Health: WHF initiatives

Objectives: To present work related to WHF initiatives aiming to improve the implementation of cardiovascular cost effective strategies in order to achieve the SDGs goal for cardiovascular diseases

Speaker biographies are available at http://www.gw-icc2017.org/en/1/myhtml/39.jsp?navbarParentId=5

Further information on the 29th GW-ICC, to be held October 11th -14th, 2018, in Beijing, China, is available on the congress website: http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at http://cvia-journal.org/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees. 

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

Updated: October 8, 2018 — 10:58 am
Cardiovascular Innovations and Applications is indexed in the ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases
EX-Lib-90x50 OCLC-90x50 sherpa NISC logo
Directory of Open Access Journals index-copernicus logo
CVIA Journal © 2015